Flow Traders U.S.’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Flow Traders U.S.’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,895	Closed	-$719K	–	1164
2022 Q3	$719K	Buy	+17,895	New	+$765K	0.04%	414
2021 Q4	–	Sell	-7,971	Closed	-$378K	–	1161
2021 Q3	$378K	Sell	7,971 -5,133	-39%	-$255K	0.02%	779
2021 Q2	$678K	Buy	+13,104	New	+$658K	0.03%	503
2020 Q4	–	Sell	-19,965	Closed	-$868K	–	800
2020 Q3	$868K	Buy	+19,965	New	+$875K	0.06%	239

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Flow Traders U.S.'s XPH Position: Q4 2022 in Review

Flow Traders U.S. sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2022, closing a stake of 17,895 shares — an estimated $719K sold.

Flow Traders U.S. first reported a position in XPH in Q3 2020 and held it in 4 quarters. The position peaked at $868K in Q3 2020. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2022.

Flow Traders U.S. reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2022 after selling out during the quarter.
Flow Traders U.S. sold 17,895 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2022, an estimated $719K.
Flow Traders U.S. first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2020 and held it in 4 quarters.
Flow Traders U.S.'s State Street SPDR S&P Pharmaceuticals ETF position peaked at $868K in Q3 2020.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2022.

Based on Flow Traders U.S.'s 13F filing for Q4 2022, filed 14 Feb 2023.